Retrieve available abstracts of 48 articles: HTML format
Single Articles
May 2025
WEHBE S, Gallwas J, Grundker C Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces
Aggressiveness of Cervical Carcinoma Cells.
Anticancer Res. 2025;45:1793-1805. PubMedAbstract available
BAL J, Fulawka L, Gabrys M, Murawski M, et al Potential Role of PTEN and AKT/PKB Proteins in the Pathogenesis of Ovarian Mature
Teratomas.
Anticancer Res. 2025;45:1843-1851. PubMedAbstract available
SIMONETTI E, Pistolesi S, Ferrari A, Della Rosa M, et al Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical
Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study.
Anticancer Res. 2025;45:2041-2050. PubMedAbstract available
TSUKAMOTO YO, Ohtsuka T, Yamauchi Y, Mun M, et al Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases
From Ovarian Cancer.
Anticancer Res. 2025;45:2071-2078. PubMedAbstract available
April 2025
DAMPALI R, Nikolettos K, Psilopatis I, Kostaki EG, et al The Impact of Body Mass Index on Sentinel Lymph Node Identification in
Endometrial Cancer.
Anticancer Res. 2025;45:1575-1581. PubMedAbstract available
March 2025
WU YC, Ku MH, Huang WL, Dias L, et al NEAT1 in Ovarian Cancer: A Key Regulator of Tumor Progression, Follicular Fluid
Dynamics, and Therapeutic Resistance.
Anticancer Res. 2025;45:825-842. PubMedAbstract available
AHMADU T, Olawade DB, Teke J, Bachour ME, et al Diagnosis and Treatment of Gestational Non-Epithelial Ovarian Cancer: A
Systematic Review.
Anticancer Res. 2025;45:843-853. PubMedAbstract available
KOH JW, Park SJ Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical
Cancer Cells.
Anticancer Res. 2025;45:989-1000. PubMedAbstract available
February 2025
STUEBS FA, Dietl AK, Schulmeyer CE, Behrens AS, et al Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in
Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women.
Anticancer Res. 2025;45:677-683. PubMedAbstract available
SANTANA BN, Arencibia O, Babin G, Tommasetti E, et al Use of Indocyanine Green Fluorescence Angiography to Assess Bowel Anastomosis in
Ovarian Cancer Surgery.
Anticancer Res. 2025;45:661-666. PubMedAbstract available
SHIEH PC, Shih HY, Chuang CL, Tsai CW, et al Association of Matrix Metalloproteinase-1 Promoter Genotypes With Endometriosis
Risk.
Anticancer Res. 2025;45:465-471. PubMedAbstract available
January 2025
TALIJANOVIC M, Lopacinska-Jorgensen J, Hogdall EV Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict
Platinum-based Chemotherapy Resistance.
Anticancer Res. 2025;45:11-26. PubMedAbstract available
KARSTENSEN S, Kaiser K, Poulsen TS, Jochumsen K, et al Ovarian Adult Granulosa Cell Tumors: A Scoping Review of DNA Alterations and
Their Known Significance.
Anticancer Res. 2025;45:1-10. PubMedAbstract available
LINDQVIST PG, Gissler M Improved Vitamin D Status Is Associated With Lower Incidence of Stillbirth.
Anticancer Res. 2025;45:243-250. PubMedAbstract available
December 2024
KONTOMANOLIS E, Koutras A, Mitrakas AG, Trypsianis G, et al Tissue Expression and Plasma Soluble PD-L1 Levels in Patients With Endometrial
Cancer.
Anticancer Res. 2024;44:5525-5530. PubMedAbstract available
ULKER EB, Aktas EC, Seyhan MF, Isbir T, et al Effects of Curcumin and Its Analogue Desmethoxycurcumin on miR-133b and Its
Target Gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells.
Anticancer Res. 2024;44:5351-5359. PubMedAbstract available
CHO Y, Kim HS Immunohistochemical Expression and Significance of Preferentially Expressed
Antigen in Melanoma (PRAME) in Gynecological Tumors: A Single-institution
Retrospective Analysis.
Anticancer Res. 2024;44:5515-5524. PubMedAbstract available
November 2024
LENZ C, Gesemann L, Al-Baldawi Y, Pusken M, et al Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage
in Patients With Cervical Cancer.
Anticancer Res. 2024;44:5081-5085. PubMedAbstract available
NA JM, Kim HS Comprehensive Clinicopathological and Immunohistochemical Analysis of Human
Papillomavirus-independent Squamous Cell Carcinoma and Adenosquamous Carcinoma of
the Uterine Cervix.
Anticancer Res. 2024;44:4969-4981. PubMedAbstract available
COCCHI S, Lopacinska-Jorgensen J, Hogdall EV Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy
Resistance in Patients With High-grade Serous Ovarian Cancer.
Anticancer Res. 2024;44:4691-4707. PubMedAbstract available
LEE HM, Cho HJ, Lee YM, Kim HJ, et al Fostamatinib Inhibits the Proliferation of Ovarian Cancer Cells Through Apoptosis
Induction.
Anticancer Res. 2024;44:4895-4903. PubMedAbstract available
SIN J, Kiosea M, Mahdavi K, Akbarpour F, et al Investigation of the Efficacy of Nowarta110 in the Treatment of HPV-16 and HPV-18
Oncogenically-transformed Human Cells and Cancer-implanted Animal Models.
Anticancer Res. 2024;44:4723-4728. PubMedAbstract available
LEE J, Chi SA, Choi S, Kim HS, et al Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix: Comparison
of Its Clinicopathological Characteristics and Programmed Death-ligand 1
Expression Status With Those of Other Endocervical Adenocarcinomas.
Anticancer Res. 2024;44:5007-5022. PubMedAbstract available
October 2024
SANTANA BN, Guyon F, Arencibia O, Babin G, et al Factors Limiting Ostomy Reversal After Cytoreductive Surgery for Ovarian Cancer:
A Retrospective Study.
Anticancer Res. 2024;44:4413-4418. PubMedAbstract available
LEE J, Heo K Repurposing Valrubicin as a Potent Inhibitor of Ovarian Cancer Cell Growth.
Anticancer Res. 2024;44:4301-4307. PubMedAbstract available
HA H, Ryu JY, Yoon S, Cho YJ, et al Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer.
Anticancer Res. 2024;44:4273-4282. PubMedAbstract available
September 2024
SMOLARZ B, Lukasiewicz H, Samulak D, Kolacinski R, et al Hypoxia-induced Factor-1alpha and its Role in Endometrial Cancer.
Anticancer Res. 2024;44:3697-3712. PubMedAbstract available
August 2024
KYRIAZOGLOU A, Papachristou DJ, Moutafi M, Papakosta A, et al Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma.
Anticancer Res. 2024;44:3331-3336. PubMedAbstract available
HIRAKAWA T, Yotsumoto F, Imi S, Ito N, et al Adipose-derived Mesenchymal Stem Cell Transplantation Improves Ovarian Function
and Oocyte Quality in Aged Mice.
Anticancer Res. 2024;44:3577-3586. PubMedAbstract available
July 2024
LI Q, Guan T, Mao J, King BP, et al Mast Cell-related Prognosis Signature Characterizes Immune Landscape and Predicts
Prognosis of Ovarian Cancer.
Anticancer Res. 2024;44:2775-2786. PubMedAbstract available
CHIEN HJ, Wang YC, Chang WS, Hsieh YH, et al Contribution of Matrix Metalloproteinase-7 Genotypes to Endometriosis Risk in
Taiwan.
Anticancer Res. 2024;44:3051-3058. PubMedAbstract available
CHOI EY, Han EJ, Jeon SJ, Lee SW, et al Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via
Inactivation of the PI3K/AKT/mTOR Signaling Pathway.
Anticancer Res. 2024;44:2961-2972. PubMedAbstract available
MAFUNE S, Someya M, Hasegawa T, Tsuchiya T, et al Analysis of Treatment Response With Proteins Related to Tumor Immunity in
Postoperative Irradiated Cervical Cancer Patients.
Anticancer Res. 2024;44:3077-3086. PubMedAbstract available
ZHANG Y, Niu X, Wang Y, Bao S, et al SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine
Metabolism via the MEK/ERK/C-Myc Axis.
Anticancer Res. 2024;44:2861-2870. PubMedAbstract available
June 2024
LEONHARDI J, Horn LC, Aktas B, Denecke T, et al MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer -
Associations With Histopathology.
Anticancer Res. 2024;44:2709-2716. PubMedAbstract available
MORGENSTERN B, Thangarajah F, Schmidt M, Lenz C, et al Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell
Carcinoma.
Anticancer Res. 2024;44:2621-2626. PubMedAbstract available
KITSOS-KALYVIANAKIS K, Pitsikakis K, Mamalis ME, Kalampokis E, et al Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian
Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence.
Anticancer Res. 2024;44:2645-2652. PubMedAbstract available
May 2024
YAMAOKA Y, Tamura S, Yamanoi K, Taki M, et al Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced
Cervical Squamous Cell Carcinoma.
Anticancer Res. 2024;44:2009-2019. PubMedAbstract available
JUNG BC, Woo SH, Kim SH, Kim YS, et al Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells.
Anticancer Res. 2024;44:1853-1862. PubMedAbstract available
WILLSON CM, Lequio M, Zhu Z, Wakefield MR, et al The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells.
Anticancer Res. 2024;44:1807-1815. PubMedAbstract available
KUM SJ, Jung YY, Kim HS Comparison of Clinicopathological and Prognostic Characteristics Between Minimal
Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
Anticancer Res. 2024;44:2193-2204. PubMedAbstract available
MOREA A, Saravi S, Sisu C, Hall M, et al Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model.
Anticancer Res. 2024;44:1817-1827. PubMedAbstract available
April 2024
XU X, Wang Q, Shen L, Shen Y, et al Anlotinib Inhibits Ovarian Cancer and Enhances Cisplatinum Sensitivity via
Suppressing NOTCH2 Expression and Stemness.
Anticancer Res. 2024;44:1399-1407. PubMedAbstract available
TSENG CC, Ku MH, Wu YC, Huang WL, et al Therapeutic Options Targeting the Ataxia-Telangiectasia Mutated (ATM)-mediated
DNA Damage Response, Macropinocytosis, and Adaptive Immunity in Ovarian Cancer.
Anticancer Res. 2024;44:1353-1364. PubMedAbstract available
CHU J, Lee SH, DO SI, Kim HS, et al Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex
Expression in Endometrial Carcinoma.
Anticancer Res. 2024;44:1739-1750. PubMedAbstract available
AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based
Brachytherapy for Cervical Cancer.
Anticancer Res. 2024;44:1583-1589. PubMedAbstract available
WANG X, Li C, Lou L, Zhu H, et al Roles of Matrix Metalloproteinases 2 and 9 in Uterine Leiomyosarcoma.
Anticancer Res. 2024;44:1465-1473. PubMedAbstract available
March 2024
KIM JS, Shin MJ, Lee SY, Choi SM, et al BBT-877, a Novel Autotaxin Inhibitor, Abrogates Drug Resistance in Epithelial
Ovarian Cancer Stem Cells.
Anticancer Res. 2024;44:1131-1142. PubMedAbstract available